Pronostic maternel et fœtal au cours de l’accouchement chez la femme excisée

Millogo-Traoré, F; Kaba, Sidiki; Thiéba, Blandine; Akotionga, M; Lankoandé, J.

doi:10.1016/s1637-4088(07)79643-8

Cited by 4 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Healthcare utilisation associated with FGM was based on a review and meta-analysis of the literature on clinical complications associated with FGM 19–109. All complications for which a significant association with FGM was found, and for which corresponding interventions could be identified, were included in the healthcare utilisation calculations.…”

Section: Methodsmentioning

confidence: 99%

Economic burden of female genital mutilation in 27 high-prevalence countries

et al. 2022

View full text Add to dashboard Cite

BackgroundFemale genital mutilation (FGM) is a traditional harmful practice affecting 200 million women and girls globally. Health complications of FGM occur immediately and over time, and are associated with healthcare costs that are poorly understood. Quantifying the global FGM-related burden is essential for supporting programmes and policies for prevention and mitigation.MethodsHealth complications of FGM are derived from a meta-analysis and stratified by acute, uro-gynaecological, obstetric and psychological/sexual. Treatment costs are calculated from national cohort models of 27 high-burden countries over 30 years. Savings associated with full/partial abandonment are compared with a current incidence reference scenario, assuming no changes in FGM practices.ResultsOur model projects an increasing burden of FGM due to population growth. As a reference scenario assuming no change in practices, prevalent cases in 27 countries will rise from 119.4 million (2018) to 205.8 million (2047). Full abandonment could reduce this to 80.0 million (2047), while partial abandonment is insufficient to reduce cases. Current incidence economic burden is US$1.4 billion/year, rising to US$2.1 billion/year in 2047. Full abandonment would reduce the future burden to US$0.8 billion/year by 2047.ConclusionFGM is a human rights violation, a public health issue and a substantial economic burden that can be avoided through effective prevention strategies. While decreasing trends are observed in some countries, these trends are variable and not consistently observed across settings. Additional resources are needed to prevent FGM to avoid human suffering and growing costs. The findings of this study warrant increased political commitment and investment in the abandonment of FGM.

show abstract

Section: Methodsmentioning

confidence: 99%

Economic burden of female genital mutilation in 27 high-prevalence countries

et al. 2022

View full text Add to dashboard Cite

show abstract

“…After removing duplicates (leaving 106 unique references) and excluding 34 articles based on titles and abstracts, we assessed the 72 full remaining texts. Sixty-one of these articles were excluded because they were descriptive (n=7), did not match nor adjust for [17][18][19][20][21][22][23][24][25][26][27] Eight studies were conducted in Africa 19-21 23-27 and three in Europe. 17 18 22 Altogether, the studies included 111 558 participants, 61 218 of whom had undergone FGM.…”

Section: Characteristics Of Studies Found In the Literaturementioning

confidence: 99%

A systematic review and meta-analysis of the consequences of female genital mutilation on maternal and perinatal health outcomes in European and African countries

Sylla

Andro

2020

BMJ Glob Health

View full text Add to dashboard Cite

IntroductionKey knowledge gaps remain to improve reproductive health outcomes for millions of women living with female genital mutilation (FGM). We aimed to update previous reviews and quantify more rigorously maternal and perinatal complications related to FGM across different settings.MethodsIn this systematic review and meta-analysis, we searched 15 electronic databases for studies published between 1 August 1995 and 15 March 2020, reporting on maternal and perinatal complications related to FGM. We included studies comparing women with and without FGM while accounting for confounders. Pooled relative risks (RR) were calculated, using fixed-effects and random-effects models, for a range of maternal and perinatal outcomes, adjusting for individual characteristics and according to delivery settings and study design.ResultsWe identified 106 unique references, assessed 72 full-text articles and included 11 studies. We found non-significant elevated risks of instrumental delivery, caesarean delivery, episiotomy, postpartum haemorrhage, perineal laceration, low Apgar score and miscarriage/stillbirth related to FGM. Heterogeneity was present for most outcomes when combining all studies but reduced in subgroup analyses. The risk of caesarean delivery was increased among primiparous women (1.79, 95% CI 1.04 to 3.07) such as the risk of episiotomy in European specialised settings for women with FGM (1.88, 1.14 to 3.09). In Africa, subgroup analyses revealed elevated risks of postpartum haemorrhage (2.59, 1.28 to 5.25). The most common reported type was FGM II. However, few studies provided stratified analyses by type of FGM, which did not allow an assessment of the impact of the severity of typology on studied outcomes.ConclusionThis review suggests maternal and perinatal morbidity related to FGM vary by study design, context and by subgroup of women. Our study also draws attention to the complications that may extend to the postpartum period. This work contributes to shaping a reference framework for future research and clinical guidelines.

show abstract

“…Meta-analyzable studies were previously acknowledged by Berg, Odgaard-Jensen et al [7] in their meta-analysis. Among these, the 2006 WHO study [9], the Berardi et al study [10], the Chibber et al study [11], the De Silva et al study [12], the Jones et al study [13], the Millogo-Traore et al study [14] and the Wuest et al study [15] are prospective studies. We re-screened the above mentioned prospective studies in order to correlate adverse obstetric outcomes to the rate of type III female genital mutilation.…”

Section: Methodsmentioning

confidence: 99%